Literature DB >> 23537858

Recent developments in the genetics of autism spectrum disorders.

John D Murdoch1, Matthew W State.   

Abstract

The last several years have marked a turning point in the genetics of autism spectrum disorder (ASD) due to rapidly advancing genomic technologies. As the pool of bona fide risk genes and regions accumulates, several key themes have emerged: these include the important role of rare and de novo mutation, the biological overlap among so-called syndromic and 'idiopathic' ASD, the elusive nature of the common variant contribution to risk, and the observation that the tremendous locus heterogeneity underlying ASD appears to converge on a relatively small number of key biological processes. Perhaps most striking has been the revelation that ASD mutations show tremendous phenotypic variability ranging from social disability to schizophrenia, intellectual disability, language impairment, epilepsy and typical development.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23537858     DOI: 10.1016/j.gde.2013.02.003

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  60 in total

1.  Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.

Authors:  ChangHui Pak; Tamas Danko; Yingsha Zhang; Jason Aoto; Garret Anderson; Stephan Maxeiner; Fei Yi; Marius Wernig; Thomas C Südhof
Journal:  Cell Stem Cell       Date:  2015-08-13       Impact factor: 24.633

2.  Maternal exposure to intimate partner abuse before birth is associated with autism spectrum disorder in offspring.

Authors:  Andrea L Roberts; Kristen Lyall; Janet W Rich-Edwards; Alberto Ascherio; Marc G Weisskopf
Journal:  Autism       Date:  2015-02-06

3.  The parvalbumin/somatostatin ratio is increased in Pten mutant mice and by human PTEN ASD alleles.

Authors:  Daniel Vogt; Kathleen K A Cho; Anthony T Lee; Vikaas S Sohal; John L R Rubenstein
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

Review 4.  The role of de novo mutations in the genetics of autism spectrum disorders.

Authors:  Michael Ronemus; Ivan Iossifov; Dan Levy; Michael Wigler
Journal:  Nat Rev Genet       Date:  2014-01-16       Impact factor: 53.242

Review 5.  Glycan susceptibility factors in autism spectrum disorders.

Authors:  Chrissa A Dwyer; Jeffrey D Esko
Journal:  Mol Aspects Med       Date:  2016-07-11

6.  Clustering of co-occurring conditions in autism spectrum disorder during early childhood: A retrospective analysis of medical claims data.

Authors:  Troy Vargason; Richard E Frye; Deborah L McGuinness; Juergen Hahn
Journal:  Autism Res       Date:  2019-05-31       Impact factor: 5.216

Review 7.  Inhibition-Based Biomarkers for Autism Spectrum Disorder.

Authors:  April R Levin; Charles A Nelson
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

8.  Why autism must be taken apart.

Authors:  Lynn Waterhouse; Christopher Gillberg
Journal:  J Autism Dev Disord       Date:  2014-07

9.  Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis.

Authors:  Finale Doshi-Velez; Yaorong Ge; Isaac Kohane
Journal:  Pediatrics       Date:  2013-12-09       Impact factor: 7.124

Review 10.  Personalized medicine and human genetic diversity.

Authors:  Yi-Fan Lu; David B Goldstein; Misha Angrist; Gianpiero Cavalleri
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-24       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.